Topics

Astellas Gets Europe Okay For AML Drug Xospata

08:13 EDT 28 Oct 2019 | SCRIP

Following green lights in the US and Japan, Xospata has been approved for relapsed or refractory FLT3-positive acute myeloid leukemia...

      

Related Stories

 

Original Article: Astellas Gets Europe Okay For AML Drug Xospata

NEXT ARTICLE

More From BioPortfolio on "Astellas Gets Europe Okay For AML Drug Xospata"

Quick Search